LIDOCAINE HYDROCHLORIDE

217692 | Orange Book

Interested in this case?

Request a Demo Track this case, and find millions of cases like it, let us show you how.
Filed June 16, 2023
Type Abbreviated New Drug Application
Case Type Abbreviated New Drug Application
Ingredients LIDOCAINE HYDROCHLORIDE
Dosage Form / Route INJECTABLE and INJECTION
Patents No unexpired patents
Last Updated: 1 month, 4 weeks ago
Date Patent / Filing No. Patent and Drug Application Information
11/29/2023
Approval for LIDOCAINE HYDROCHLORIDE, 1%
  • Active Ingredient: LIDOCAINE HYDROCHLORIDE
  • Dosage Form: INJECTABLE
  • Dosage Route: INJECTION
  • Therapeutic Equivalence: Injectable aqueous solutions and, in certain instances, intravenous non-aqueous solutions
6/16/2023
Approval for LIDOCAINE HYDROCHLORIDE, 2%
  • Active Ingredient: LIDOCAINE HYDROCHLORIDE
  • Dosage Form: INJECTABLE
  • Dosage Route: INJECTION
  • Therapeutic Equivalence: Injectable aqueous solutions and, in certain instances, intravenous non-aqueous solutions
6/16/2023
Approval for LIDOCAINE HYDROCHLORIDE, 1%
  • Active Ingredient: LIDOCAINE HYDROCHLORIDE
  • Dosage Form: INJECTABLE
  • Dosage Route: INJECTION
  • Therapeutic Equivalence: Injectable aqueous solutions and, in certain instances, intravenous non-aqueous solutions
6/16/2023ORIG-1Approval: Label is not available on this site.